skip to main content

SGLT2 genital infection — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardEndocrine TherapeuticsSGLT2 genital infectionGPhC CRA

A patient on empagliflozin reports recurrent genital thrush and asks why it happens. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Explain it is a recognised effect and advise hygiene plus clinical review if recurrent

SGLT2 inhibitors increase glycosuria and can predispose to genital mycotic infections. In this vignette, "Explain it is a recognised effect and advise hygiene plus clinical review if recurrent" is the safest single best answer. The other options are less appropriate because they miss the key clinical risk, conflict with UK medicines guidance, or delay needed review.

Reference: BNF; NICE CKS